Verona Pharma (NASDAQ:VRNA) Earns "Buy" Rating from Truist …

6 days ago · Verona Pharma (NASDAQ:VRNA - Get Free Report) last issued its quarterly earnings results on Monday, November 4th.The company reported ($0.56) EPS for the …

$0.56
OFF

Verona Pharma (NASDAQ:VRNA) Earns "Buy" Rating From Truist …

2 weeks from now

6 days ago · Verona Pharma (NASDAQ:VRNA - Get Free Report) last issued its quarterly earnings results on Monday, November 4th.The company reported ($0.56) EPS for the …

marketbeat.com

$45.20
OFF

Verona Pharma (NASDAQ:VRNA) Receives “Buy” Rating From …

2 weeks from now

4 days ago · Verona Pharma stock opened at $45.20 on Wednesday. The business has a 50 day moving average of $41.33 and a 200-day moving average of $31.52. The company has a …

etfdailynews.com

$57
OFF

Verona Pharma Price Target Raised To $57 From $44 At Truist

2 weeks from now

6 days ago · Truist raised the firm’s price target on Verona Pharma (VRNA) to $57 from $44 and keeps a Buy rating on the shares. The firm cites the company’s positive Q4 revenue pre …

nasdaq.com

$47.83
OFF

Truist Financial Releases A Buy Rating On Verona Pharma (VRNA)

2 weeks from now

Dec 23, 2024 · Verona Pharma has an analyst consensus of Strong Buy, with a price target consensus of $47.83. See Insiders’ Hot Stocks on TipRanks >> VRNA market cap is currently …

businessinsider.com

$38.00
OFF

Verona Pharma (NASDAQ:VRNA) Sets New 1-Year High - Here's …

2 weeks from now

Dec 23, 2024 · Truist Financial increased their price objective on shares of Verona Pharma from $38.00 to $44.00 and gave the stock a "buy" rating in a research report on Wednesday, …

marketbeat.com

$77
OFF

Verona Pharma Price Target Raised To $77 From $51 At BTIG - Nasdaq

2 weeks from now

6 days ago · BTIG raised the firm’s price target on Verona Pharma (VRNA) to $77 from $51 and keeps a Buy rating on the shares. The company’s Q4 pre-announcement was "impressive", …

nasdaq.com

$37.00
OFF

Buy Rating Affirmed For Verona Pharma: Breakthrough COPD …

2 weeks from now

Aug 14, 2024 · Canaccord Genuity analyst Edward Nash maintained a Buy rating on Verona Pharma (VRNA – Research Report) yesterday and set a price target of $37.00.. Edward Nash …

businessinsider.com

$68
OFF

Verona Pharma Initiated With A Buy At Roth MKM - Markets Insider

2 weeks from now

5 days ago · Roth MKM analyst Boobalan Pachaiyappan initiated coverage of Verona Pharma (VRNA) with a Buy rating and $68 price target The firm says its investment thesis is driven by …

businessinsider.com

FAQs about Verona Pharma (NASDAQ:VRNA) Earns "Buy" Rating from Truist … Coupon?

Should you buy Verona Pharma (vRNA – research report)?

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Verona Pharma (VRNA – Research Report). The company’s shares closed last Friday at $46.59. According to TipRanks, Lee is a 5-star analyst with an average return of 23.9% and a 50.15% success rate. ...

Should you buy Verona Pharma (Verona) stock?

According to TipRanks, Lee is a 5-star analyst with an average return of 23.9% and a 50.15% success rate. Lee covers the Healthcare sector, focusing on stocks such as Verona Pharma, Wave Life Sciences, and AnaptysBio. Currently, the analyst consensus on Verona Pharma is a Strong Buy with an average price target of $50.20. ...

Should you buy Lee & Verona Pharma?

According to TipRanks, Lee has an average return of 29.8% and a 55.24% success rate on recommended stocks. Verona Pharma has an analyst consensus of Strong Buy, with a price target consensus of $47.00, implying a 20.51% upside from current levels. ...

What percentage of Verona Pharma stock are owned by insiders?

In the past three months, Verona Pharma insiders have sold 5,060.08% more of their company's stock than they have bought. Specifically, they have bought $188,928.00 in company stock and sold $9,748,833.00 in company stock. Only 4.80% of the stock of Verona Pharma is held by insiders. 85.88% of the stock of Verona Pharma is held by institutions. ...

What was Verona Pharma's stock price on January 1st 2024?

Verona Pharma's stock was trading at $19.88 on January 1st, 2024. Since then, VRNA shares have increased by 114.7% and is now trading at $42.68. How were Verona Pharma's earnings last quarter? Verona Pharma plc (NASDAQ:VRNA) issued its earnings results on Monday, November, 4th. ...

When did Verona Pharma IPO?

Verona Pharma (VRNA) raised $61 million in an initial public offering (IPO) on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel served as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers. ...